Recent Posts

Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration

[ad_1] A review we just published on Emerging Anti-VEGF Agents for Neovascular AMD… http://www.tandfonline.com/eprint/KbY55Gyay3kpEMxMDmuQ/full Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration (2017). Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration. Expert Opinion on Emerging Drugs. Ahead 

Physician MBAs and faculty publish research on improving clinic wait times in prominent journal: News Stories: News: Kelley Indianapolis Hub: Indiana University–Purdue University Indianapolis

Physician MBAs and faculty publish research on improving clinic wait times in prominent journal: News Stories: News: Kelley Indianapolis Hub: Indiana University–Purdue University Indianapolis

[ad_1] Our study published in the journal, Retina: Lean Six Sigma to improve patient care, satisfaction & minimize waste… https://hub.kelley.iupui.edu/news/_news/physician-mbas-and-faculty-publish-research-on-improving-clinic-wait-times.html Physician MBAs and faculty publish research on improving clinic wait times in prominent journal: News Stories: News: Kelley Indianapolis Hub: Indiana University–Purdue University Indianapolis Physician 

Gene therapy for age-related macular degeneration

[ad_1]
A review we recently published on Gene Therapy for Age-Related Macular Degeneration…

http://www.tandfonline.com/eprint/uYXmhvqRXXwC8zsBbtU6/full

Gene therapy for age-related macular degeneration

(2017). Gene therapy for age-related macular degeneration. Expert Opinion on Biological Therapy. Ahead of Print.
[ad_2]

Return to main website.

Induced pluripotent stem cell-based therapy for age-related macular degeneration

[ad_1] A review we recently published on Induced Pleuripotent Stem Cell Therapy for Age-Related Macular Degeneration… http://www.tandfonline.com/eprint/HAaHd467cGtbjFADFQzV/full Induced pluripotent stem cell-based therapy for age-related macular degeneration (2017). Induced pluripotent stem cell-based therapy for age-related macular degeneration. Expert Opinion on Biological Therapy. Ahead of Print. doi: 

Ophthalmology Management –

[ad_1] A clinical case series on “Real World” OCT authored by Peter Bracha and Dr. Ciulla in June’s issue of Ophthalmology Management… Ophthalmology Management – ltra-high resolution optical coherence tomography (OCT) systems can generate superb atlas-grade images that readily highlight macular pathology. However, instead of 

5 ways to get better Wi-Fi, from your living room to your backyard

[ad_1]

5 ways to get better Wi-Fi, from your living room to your backyard

Be ready to surf the web this summer
[ad_2]

Return to main website.

Retinal Physician – Dry AMD Masquerade Syndromes

[ad_1] A recent article authored by Dr. Peter Bracha and Dr. Ciulla on “Dry AMD Masquerades”… http://www.retinalphysician.com/issues/2017/january-2017/dry-amd-masquerade-syndromes Retinal Physician – Dry AMD Masquerade Syndromes Article Dry AMD Masquerade Syndromes The authors present examples of pattern and cone-rod dystrophies, and maculopathies associated with medication toxicity or 

Sonepcizumab combination therapy may offer long-term visual acuity stabilization

[ad_1] Presented during Retina Subspecialty Day at the 2015 meeting of the American Academy of Ophthalmology, this article was published in the November 15, 2016 print version of Ophthalmology TImes… http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/sonepcizumab-combination-therapy-may-offer-long-term-visual-acuity-stabilization?page=0,2 Sonepcizumab combination therapy may offer long-term visual acuity stabilization Take-home: Sonepcizumab alone or in 

Real-World Anti-VEGF Data Disappointing

[ad_1]
Dr. Ciulla’s recent presentation at the annual meeting of The American Society of Retina Specialists was featured on Medscape:
http://www.medscape.com/viewarticle/867391

Real-World Anti-VEGF Data Disappointing

Administered under real-life circumstances, anti-VEGF treatments produce much worse results than they do in clinical trials, according to an analysis of 750,000 patients in the US.
[ad_2]

Return to main website.

Targeting VEGF’s Silent Partners in DME

[ad_1] Article written by Drs. Rehan Hussain and Ciulla on therapies for diabetic macular edema, a common cause of vision loss: http://www.reviewofophthalmology.com/article/targeting-vegfs-silent-partners-in-dme Targeting VEGF’s Silent Partners in DME Rehan M. Hussain, MD, Thomas A. Ciulla, MD, MBA, Indianapolis Published 5 August 2016 Targeting VEGF’s Silent